Skip to content
BioPharma
AI Product Solutions
Translational Research
Clinical Development Services
Real-World Data
Companion Diagnostics
IHCExplore™
PathExplore™
LiverExplore™
IBDExplore™
Deep Bio
Paige
Visiopharm
DoMore Diagnostics
Central Pathology Laboratory Operations
AISight®️ Clinical Trials
AI-Enabled Clinical Development
Deep Bio
Paige
Visiopharm
DoMore Diagnostics
Anatomic Pathology
AISight®️ Digital Pathology Platform
AI Product Solutions
Precision Pathology Network
AISight®️ Image Management System (RUO)
AISight®️ Dx Digital Pathology Platform (FDA 510(k) cleared)
Deep Bio
Paige
Visiopharm
DoMore Diagnostics
PathAI Algorithm Products
ArtifactDetect
TumorDetect
AIM-Tumor Cellularity
PathAssistDerm
AIM-PDL1
AIM-HER
AIM-ER
AIM-PR
AIM-Ki67
AIM-MASH
AIM-HI-UC
METPredict
Partner Algorithm Products
Deep Bio
Paige
Visiopharm
DoMore Diganostics
Deep Bio
Paige
Visiopharm
DoMore Diagnostics
News and Resources
Press Releases
Publications
Blog
About Us
Our History
Leadership Team
Careers
Contact Us
Request a Demo
Search
BioPharma
Menu
Biopharma
Translational Research
Clinical Development Services
Real-World Data
Companion Diagnostics
Anatomic Pathology
Menu
Anatomic Pathology
AISight®️ Digital Pathology Platform
AISight®️ Image Management System
AISight®️ Dx
AI Product Solutions
PathAI Algorithm Products
ArtifactDetect
TumorDetect
AIM-Tumor Cellularity
PathAssistDerm
PathAssistDerm
AIM-PDL1
AIM-HER
AIM-ER
AIM-PR
AIM-Ki67
AIM-MASH
AIM-HI-UC
METPredict
Partner Algorithm Products
DeepBio
Paige
Visopharm
DoMore Diagnostics
Precision Pathology Network
News and Resources
Menu
News and Resources
Press Releases
Publications
Blog
About Us
Menu
About Us
Our History
Leadership Team
Careers
Contact Us
Login
Request a Demo
Back to Publications
Real-world performance of AI-based tumor cell content (TCC) quantification
June 25, 2025
Conference
ECDP 2025
View Poster
Authors
Runge et al. (USZ)
